GLP-1 Start: Dosing Q's and Concerns!

Hong Kong Yanpep International
You're right about that cost-benefit trade-off. It's really individual, you know? The way I look at it, the trial data gives us a solid foundation. Looking at what the RCTs actually showed and comparing that to where your health is at right now, that's how you figure out what dose makes sense. The thing is, everyone's different. How much you match up with the people in those studies matters. Plus what you're actually trying to get out of the medication. I see people ask for a dose rec without much context, and honestly you can't do that responsibly. You need to know about the person, their stats, what they want to achieve. That's the real starting point.
 
Washout periods used to be talked about on forums - run for a bit then reset. Don't see that discussion much anymore.
 
The study itself admits some gaps in the conclusion. It's basically proof of concept at this stage. Shows that some people can maintain on lower dosing schedules, but way bigger trials are needed.
 
If appetite suppression is the primary goal, the Tirz vs Reta distinction matters a lot. Tirz tends to be the stronger option on that specific effect. Starting doses across all of them should be conservative regardless of which direction you go. What are each of your buddies actually trying to optimize for - weight or something else?
 
Titrating up as the logical next step when results plateau is the consistent recommendation. Having room to escalate and not yet hitting the ceiling is actually the better position. The differences between the three options on hunger suppression are real - Reta tends to be less consistent on appetite alone, which matters for which one makes sense for a given goal.
 
30kg down and 10 more to go puts you in the phase where the dose math changes relative to where you started. At that point the question shifts from what it takes to start losing to what's the minimum that keeps things moving. Starting doses for the OP's buddies is a different calculation from maintenance dosing on an established protocol. What's the specific concern - GI effects, dose ceiling, or something else?
 
Started reta at .5 since tirz didn't sit well with me. Slowly worked my way to 2mg without any side effects. Some people respond at .5, others get rough reactions. Makes sense to ease in gradually to sidestep that, unless you already know your body needs a much higher amount before GLP1 does anything at all.

Plenty of people doubt low amounts work, even though evidence keeps piling up showing certain people thrive on them. Doesn't show up in clinical trials since those small amounts never got tested there, and honestly I doubt the drug companies are eager to discover how little medication actually gets the job done given what that would mean for their bottom line. Individual reports collectively show that the 'effective' range stretches surprisingly wide.
 
Currently running tirzepatide, but stocked up on a bunch of R20 kits... planning to fold reta into my GLP routine, and rather than starting off with the R20s, grabbed a couple R10 kits instead since the math works out better for my initial dosing... so count me in on the 10s side... :)
 
It's honestly kind of wild. Some people around here clearly have a high tolerance for risk and love experimenting. Personally stacking two GLP-1 receptor agonists together strikes me as odd and potentially risky. Feels more logical to first push toward the highest tested and tolerated dose of one, then only add a second mechanism if more is genuinely needed. The tricky part is figuring out when 'more' actually applies, and what pace of loss even counts as optimal. Hard to answer any of that without real medical oversight involved.
 
Working on tapering Tirz while raising Reta, though I've been nervous about overdoing the combined total.

Was running 15 on Tirz, just dropped to 12.5 and bringing Reta in at 2mg starting now.
Aiming for 12.5mg Tirz paired with 4mg Reta within a few weeks to see how that feels...

Built myself a chart tracking dosage, wanted to avoid crossing roughly 27mg total GLP-1 circulating when I was still at 15mg Tirz alone, aiming to hold the average somewhere around 18-19mg. But it looks like plenty of you are running way past that range! Any published research on where the safety ceiling actually sits?
 
tofu_ozalumna Wouldn't it make sense to start both at the lowest doses, since GLP stacks may cause more side effects as both climb? A pro coach I listen to recommends low dose reta plus tirz, has had great results, and doesn't need to raise either dose high. I found that interesting.
 
The main kinda reason is that most information on GLP peptides comes from online users rather than experts, not from studies or official drug info (which doesn't exist yet for reta). A few percent, maybe up to 10%, get unpleasant kinda side effects after starting at 2mg, and those people are ten times likelier to post online about bad side effects from kinda following the standard kinda recipe than those who had none. So online info tilts heavily toward people who reacted badly on smaller doses, & those recommending starting at one or 0.5mg come to dominate the discussions whether it's a good kinda idea or not. The manufacturer selected its starting doses deliberately, balancing low side-effect rates against how long it takes to reach a working dose.
 
Plenty of people I know decided to try bigger doses of sema and tirz long before trials had much to say, and, like the trials, the outcomes look mixed. In the end, for every one of these GLP-1s, much of it will be each person finding the dose that suits them, given how many factors differ between individuals. Approval of higher doses does give people more confidence to try them.
 
The one real effect of a high starting weight is that you'll likely need to climb toward the 12 mg maximum over time, which is a good idea anyway. Suppose he currently takes 2.4 mg of semaglutide, beginning reta at 4mg ought to work, but if sema ended some time ago, 2mg is safer, since reta has different side effects than sema, more heart rate increase and skin sensitivity but less nausea and vomiting. Type 2 diabetes adds another factor. GLP drugs rarely cause hypoglycemia alone, but paired with additional diabetes medication the odds rise, so monitor glucose carefully at the start and with dose increases. Starting at 2mg and stepping up 2mg monthly should be okay, since tolerating 2.4 of sema makes trouble very unlikely.
 
You must log in or register to reply here.
Back
Top